Navigation Links
Weizmann Institute solar technology to convert greenhouse gas into fuel
Date:6/7/2012

An Israeli-Australian venture will use solar technology developed at the Weizmann Institute of Science to reduce carbon dioxide emissions from the burning of brown coal. The venture has been recently launched in Israel by NewCO2Fuels Ltd., a subsidiary of the Australian company Greenearth Energy Ltd., which has acquired an exclusive worldwide license for the solar technology from Yeda, the Weizmann Institute's technology transfer arm.

The Weizmann technology makes use of concentrated solar energy to dissociate carbon dioxide (CO2) to carbon monoxide (CO) and oxygen (O2). This method, developed at the Weizmann Institute by Prof. Jacob Karni, also makes it possible to dissociate water (H2O) to hydrogen (H2) and oxygen (O2) at the same time it dismantles the CO2.

Carbon monoxide (CO), or its mixture with hydrogen called Syngas, can then be used as gaseous fuel, for example, in power plants, or converted to liquid fuel such as methanol, which can be stored, transported or used to power motor vehicles.

The method has proved successful in laboratory trials. NewCO2Fuels Ltd. is now building a solar reactor for the conversion of CO2 on an industrial scale. Part of the development is being performed in collaboration with the Canadian Institute for the Energies and Applied Research at the Weizmann Institute of Science.

Greenearth Energy expects the new Israeli-Australian venture to help harness the vast brown coal resources in the State of Victoria in south-eastern Australia, whose use has been limited until now by the high CO2 emission content from this type of coal. The possibility of converting CO2 to fuel in a clean and efficient manner will turn brown coal into a source of environmentally friendly fuel.


'/>"/>
Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Source:Eurekalert

Page: 1

Related biology news :

1. Esther B. OKeeffe Foundation gives $2 million to the Scripps Research Institute
2. La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
3. CUNY Energy Institute battery system could reduce buildings electric bills
4. TGen leads new National Institutes of Health study of brain tumors
5. Merkin Family Foundation to fund next generation of Broad Institute scientists
6. NJIT, Chinas Bengbu Glass Institute sign agreement for R&D, training
7. Scripps Research Institute scientists develop antidote for cocaine overdose
8. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
9. Cary Institute Hydrofracking Forum
10. Minneapolis Heart Institute selected to participate in Cardiovascular Cell Therapy Research Network
11. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
Breaking Biology Technology: